Product Information

GALANTAMINE ER 8 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.7939 per EA under NDC 47335083583. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Feb 2, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GALANTAMINE ER 8 MG CAPSULE

Galantamine Hydrobromide
$0.7939per EA

Strength

8 mg/1

NDC

47335083583

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

GALANTAMINE HYDROBROMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA090178

FDA Approved

2/2/2011

TE Code

AB

On Market Since

2/9/2011

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price Statistics

The NADAC for GALANTAMINE ER 8 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 66.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7939 per EA
All-time high$2.3623 (Feb 12, 2014)
All-time low$0.6790 (May 22, 2024)
52-week high$0.9246
52-week low$0.7782
Median price$1.5207
Average price$1.4735
Largest weekly change+84.5% (Jul 21, 2021)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+2.0%

1M

+2.0%

3M

-4.2%

6M

-2.4%

1Y

-6.4%

3Y

-21.5%

5Y

-48.9%

All

-66.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Galantamine Hydrobromide market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of GALANTAMINE ER 8 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for GALANTAMINE ER 8 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $0.7939 per EA (NDC 47335083583), effective Aug 19, 2026.

How has the price of GALANTAMINE ER 8 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for GALANTAMINE ER 8 MG CAPSULE has declined 66.3%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for GALANTAMINE ER 8 MG CAPSULE?

Since Nov 28, 2013, the NADAC for GALANTAMINE ER 8 MG CAPSULE has ranged from a low of $0.6790 (May 22, 2024) to a high of $2.3623 (Feb 12, 2014), with a median of $1.5207 per EA.

Are there cheaper alternatives to GALANTAMINE ER 8 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of GALANTAMINE ER 8 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures GALANTAMINE ER 8 MG CAPSULE?

GALANTAMINE ER 8 MG CAPSULE (NDC 47335083583) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.